
The French ICRAKI trial in NEJM found intermittent hemodialysis was not noninferior to continuous renal-replacement therapy for ICU acute kidney injury and was associated with higher 90-day mortality.

ASIC has opened consultation on standards for crypto exchanges and tokenised custody platforms under Australia’s new digital assets law, which takes effect April 8, 2027. Submissions close Nov. 27, 2026.

Character.AI has filed for Chapter 11 bankruptcy and plans to sell its assets, with Disney opening the bidding at $20 million. Here are the verified facts, the background and what happens next.

Drones hit two cargo ships off Bulgaria on Oct. 13, sinking the HS Dignity and leaving 11 sailors missing. Bulgaria summoned Russia’s ambassador. Here are the facts, reactions and what to watch next.

Bristol Myers Squibb says its first-in-class LPA1 blocker admilparant slowed lung function decline in idiopathic pulmonary fibrosis at 60 mg in the Phase 3 ALOFT-IPF trial, while the 120 mg dose fell short. Here is the science, the evidence and what comes next.

A new study of nearly 200,000 U.S. adults links eating after dinner or after bedtime to a 20% to 30% higher rate of liver disease, including fatty liver and cirrhosis. What the research found, how strong the evidence is and practical takeaways.
